On the therapeutic front, advancements in immunology are reshaping the vitiligo treatment paradigm. Systemic and immune-modulating therapies increasingly target vitiligo, an autoimmune disease. Oral ...

Vitiligo is a chronic autoimmune disease characterized by the destruction of melanocytes, the cells responsible for producing ...

An international consensus study published in JAMA Dermatology established definitions for vitiligo severity and relapse, ...

Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed ...

Vitiligo is associated with increased cardiovascular disease risk, affecting organ function and metabolic syndrome. A large-scale US study found 54 cardiovascular diseases with increased risk in ...

Add Yahoo as a preferred source to see more of our stories on Google. Kim Kardashian revealed this week that one of her two sons -- Saint, 8, or Psalm, 5 -- has the rare skin condition vitiligo. Kim ...

New study reveals higher cardiovascular risk in vitiligo patients, underscoring need for proactive care. Study: Vitiligo is associated with an increased risk of cardiovascular diseases: a large-scale, ...

Patients with vitiligo have a higher genetic risk of developing rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Similarly, many rheumatic diseases, which affect the skeletal system, ...

A mouse in which vitiligo has been induced as part of a recent NCI study. When the subjects of experimental melanoma vaccine studies lose pigment in their skin after receiving treatment, few of them ...

Detailed price information for Edesa Biotech Inc (EDSA-Q) from The Globe and Mail including charting and trades.

While discussing her psoriasis journey on Monday’s episode of the “She MD” podcast, Kardashian explained that vitiligo, which causes patches of skin to lose pigment or color, can be hereditary. “It ...